Anacor Pharmaceuticals
Latest round
- Series E
Last raised
- Jan 2009
Total raised
- $82M
Investors
- 7
About Anacor Pharmaceuticals
Anacor Pharmaceuticals, Inc.Founded in 2002, Anacor Pharmaceuticals, Inc. specializes in developing innovative treatments, particularly for dermatological conditions. The company has not publicly reported any significant changes in its business operations or strategy. It is based in Palo Alto, US.00 per share.Anacor Pharmaceuticals, Inc. focuses on developing innovative therapies primarily for dermatological conditions. Their product offerings include topical treatments that utilize their proprietary technology platform, aiming to provide effective solutions for skin disorders.In the most recent year of 2015, Anacor Pharmaceuticals, Inc.Anacor Pharmaceuticals, Inc. is strategically focused on advancing its pipeline of dermatological treatments, with plans to launch new products in the upcoming years. The company aims to expand its market presence, targeting both North America and Europe by 2022.
Who invested in Anacor Pharmaceuticals
7 investors across 4 rounds
See all investors in Anacor Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Anacor Pharmaceuticals
Who invested in Anacor Pharmaceuticals?
Anacor Pharmaceuticals has 7 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Anacor Pharmaceuticals raised?
Anacor Pharmaceuticals has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Anacor Pharmaceuticals last raise money?
Anacor Pharmaceuticals's most recent round on record is a Series E, in Jan 2009.
What does Anacor Pharmaceuticals do?
Anacor Pharmaceuticals is a pharmaceuticals company.
Where is Anacor Pharmaceuticals headquartered?
Anacor Pharmaceuticals is headquartered in Palo Alto, US.
Which VCs invest in companies like Anacor Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Anacor Pharmaceuticals's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series E
Raising like Anacor Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.